Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of B-D-Galactose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.48 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.48 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.48 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | FBP1 | P09467 | 1/20 | 0.42 |
| ▸ | PYGB | P11216 | 7/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dextrose SCHEMBL6038162 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| Beta-D-Glucose SCHEMBL361597 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL361799 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL16429773 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| Dextrose SCHEMBL7651668 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| D-Mannose SCHEMBL1772795 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| D-Galactose SCHEMBL17593535 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL361515 | 1.00 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL9847381 | 0.98 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| Ribose (Furanose) SCHEMBL27896040 | 0.98 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587505-A1 | STORAGE STABLE MICROBIAL COMPOSITION | Lanbiotic GmbH (AT) | 2025-07-23 | — | — | EP | claimed |
| WO-2024056638-A1 | STORAGE STABLE MICROBIAL COMPOSITION | LANBIOTIC GMBH (AT) | 2024-03-21 | — | — | WO | claimed |
| WO-2016116472-A1 | PRODUCTION OF SPECIFIC GLUCOSIDES WITH CELLOBIOSE PHOSPHORYLASE | UNIVERSITEIT GENT (BE) | 2016-07-28 | — | — | WO | claimed |
| EP-2593549-A2 | METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS | Universiteit Gent (BE) | 2013-05-22 | — | — | EP | claimed |
| WO-2012007481-A2 | METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS | UNIVERSITEIT GENT (BE) | 2012-01-19 | — | — | WO | claimed |
| EP-0158879-A2 | Compounds having cardiotrophic activity, a process for the preparation thereof and pharmaceutical compositions therefrom | POLI INDUSTRIA CHIMICA S.p.A. (IT) | 1985-10-23 | — | — | EP | claimed |
| EP-4587505-A1 | STORAGE STABLE MICROBIAL COMPOSITION | Lanbiotic GmbH (AT) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024056638-A1 | STORAGE STABLE MICROBIAL COMPOSITION | LANBIOTIC GMBH (AT) | 2024-03-21 | — | — | WO | disclosed |
| EP-3839041-A1 | SEMI-CONTINUOUS CULTURE METHODS | Mara Renewables Corporation (CA) | 2021-06-23 | — | — | EP | disclosed |
| EP-3472308-A1 | ENZYMATIC GLYCOSYLATION OF STEVIOL GLYCOSIDES AND OTHER COMPOUNDS WITH GLUCOSE-1-PHOSPHATE | Codexis, Inc. (US) | 2019-04-24 | — | — | EP | disclosed |
| WO-2017218324-A1 | ENZYMATIC GLYCOSYLATION OF STEVIOL GLYCOSIDES AND OTHER COMPOUNDS WITH GLUCOSE-1-PHOSPHATE | CODEXIS, INC. (US) | 2017-12-21 | — | — | WO | disclosed |
| EP-3207164-A1 | SEMI-CONTINUOUS CULTURE METHODS | Mara Renewables Corporation (CA) | 2017-08-23 | — | — | EP | disclosed |
| WO-2016116472-A1 | PRODUCTION OF SPECIFIC GLUCOSIDES WITH CELLOBIOSE PHOSPHORYLASE | UNIVERSITEIT GENT (BE) | 2016-07-28 | — | — | WO | disclosed |
| EP-2593549-A2 | METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS | Universiteit Gent (BE) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012174020-A2 | NANOPARTICLES FOR DELIVERY OF BIOACTIVE AGENTS | ROSE PHARMACEUTICALS, LLC (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012007481-A2 | METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS | UNIVERSITEIT GENT (BE) | 2012-01-19 | — | — | WO | disclosed |
| US-7968321-B1 | Ethanol production by microorganisms | JOULE UNLIMITED, INC. (US) | 2011-06-28 | — | — | US | disclosed |
| EP-0611395-A1 | IMPROVED SUPERSWEET CORN | Novartis AG (CH) | 1994-08-24 | — | — | EP | disclosed |
| WO-1993009237-A1 | IMPROVED SUPERSWEET CORN | SANDOZ LTD. (CH) | 1993-05-13 | — | — | WO | disclosed |
| US-4603108-A | Method for identification of bacterial species | NATIONAL RESEARCH DEVELOPMENT CORP. (GB) | 1986-07-29 | — | — | US | disclosed |